Flawless Pharma Private Limited - Due diligence report

A 360° intelligence report on Flawless Pharma Private Limited: trust score, financial health, credit view, compliance, directors, growth and…

2010-10-27 Mumbai, Maharashtra Active Unlisted Active Compliant
FP Flawless Pharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹449 Save ₹251 excl. GST
Or from ₹279/report with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Flawless Pharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
67/100
Trust Score
Moderate

Flawless Pharma Private Limited is assessed as Moderate with a Trust Score of 67/100. Flawless Pharma Private Limited is an active private limited indian non-government company incorporated in 2010, operating in the Pharma sector. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a high compliance risk and low financial risk profile.

Report generated on 17 Jul 2026 from the latest processed filings. Flawless Pharma Private Limited snapshot & full profile →

Overall Assessment CautionWeakNeutralGoodStrong Good
Compliance › Neutral

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreModerate
67/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreCaution Indicated
45/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
90/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreLow Risk
75/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreCaution Indicated
40/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
80/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 75/100 Low Risk
  • No open charges - unencumbered balance sheet.
  • Working-capital cover adequate.
  • Profitable - internal accruals available.

Charges position: 0 open (-) · 0 satisfied (-).

Compliance Score: 45/100 Caution Indicated
  • Company status is Active as per MCA.
  • Last balance sheet is for Mar 2023 - filings overdue.
  • Flagged by authority: MCA.
  • 1 active GST registration(s).
05

Director Intelligence

Stability score: 40/100
NameDIN / PANDesignationAppointedTenureDIN status
SUJEETKUMAR KAMALAPRASAD SINGH 01234567 Director 01/04/2018 6 yrs Approved
GAURAV PRADEEP SINGH 01234567 Director 01/04/2018 6 yrs Approved
  • 2 directors on the board.
  • SUJEETKUMAR KAMALAPRASAD SINGH has DIN status "Deactivated due to non-filing of DIR-3 KYC".
  • 1 director exit(s) in the last 3 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 80 · Distress 70
Growth signals & trust indicators
Latest year revenue grew 38%.
Profit expanded 1.42 year-on-year.
Asset base grew 2.1x - capacity expansion.
Net margin improved to 24%.
Operating for 15+ years.
Active GST registration(s).
Distress signals & risk flags
Outside liabilities up 0.86 in a year.
Statutory filings appear overdue.
Compliance score is weak (45/100).
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence59/100
Review suggested
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • 2 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment72/100
Favourable lending indicators
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • No existing security registered - first-charge position available.
  • Compliance gaps should be priced into terms.
Investor view80/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 4 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management churn warrants questions.
09

MCA Filings & Events Timeline

Latest 14 events
30 Sep 2024
Last AGM held
Annual general meeting
21 Aug 2023
Director ceased
SUJEETKUMAR KAMALAPRASAD SINGH
31 Mar 2023
Latest balance sheet
Filed with ROC
02 Jan 2023
Director appointed
SUJEETKUMAR KAMALAPRASAD SINGH (Director)
16 Sep 2021
Director ceased
PRATEEK SHYAMBAHADUR SINGH
Director ceased
GAURAV PRADEEP SINGH
07 Sep 2021
Director ceased
HIMANSHU GUPTA
Director ceased
MUNNA
01 Sep 2021
Director appointed
GAURAV PRADEEP SINGH (Director)
09 Nov 2020
Director ceased
ARJUN SINGH
09 Oct 2018
Director ceased
ATEET NANDKISHORE CHATURVEDI
Director ceased
MANOJ SHARMA
18 Mar 2011
Director ceased
SUBHASH VISHNU GOKHALE
27 Oct 2010
Incorporated
Registered with Roc Mumbai
10

Key Observations

Auto-generated from the data above
Net worth is positive.
2 active director(s) / partner(s); review board churn before relying on management continuity.
1 active GST registration(s) indicate ongoing business operations.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Indo Hitech Appliances U31909DL2017PLC320634 Delhi, Delhi, India
Anindita Fashions Private Limited U52100WB2012PTC189028 Kolkata, West Bengal, India
Shiva Veener (India) Private Limited U20296UP2008PTC035410 Lucknow, Uttar Pradesh, India
Sri Sarva Siddhi Sai Ram Warehouse Private Limited U63020AP2014PTC094897 Visakhapatnam, Andhra Pradesh, India
Transchem Corporation Pharma Private Limited U51909MH2022PTC378924 Mumbai, Maharashtra, India
Silania Associates Packaging Private Limited U74900DL2007PTC168392 Delhi, Delhi, India
A T Polymer Agency Private Limited U51392TZ1996PTC007576 Coimbatore, Tamil Nadu, India
Jai Gopal International Impex Private Limited U20200HR1992PTC031557 Bahadurgarh, Haryana, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Flawless Pharma Private Limited before audits and certifications: compliance score 45/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Flawless Pharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Favourable lending indicators. Credit risk score 75/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Flawless Pharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Review suggested. Trust score 67/100, distress signals and MSME payment-delay disclosures - know whether Flawless Pharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Flawless Pharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Flawless Pharma Private Limited an active company?

Flawless Pharma Private Limited has MCA status “Active” with a compliance score of 45/100 (Caution Indicated).

Is Flawless Pharma Private Limited financially healthy?

Flawless Pharma Private Limited has a Financial Health Score of 90/100 (Low Risk) based on its filed financial statements.

Should I do business with Flawless Pharma Private Limited?

Its overall Trust Score is 67/100 (Moderate). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Flawless Pharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 2 active director(s) are on record.

Does Flawless Pharma Private Limited have loans or charges against its assets?

No charges are registered against this company - an unencumbered balance sheet.

Is Flawless Pharma Private Limited up to date with its ROC filings?

Last balance sheet is for Mar 2023 - filings overdue. Overall compliance score: 45/100 (Caution Indicated).

Is it risky to lend to Flawless Pharma Private Limited?

Its Credit Risk Score is 75/100 (Low Risk). Banker verdict: Favourable lending indicators.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.